Meningitis trial focuses on infant response

Infants from South Australia, Western Australia, and Victoria have been recruited for the trial of a new vaccine against meningococcal disease.

Professor Don Roberton from the Adelaide Women's and Children's Hospital says the vaccine is aimed at the C and Y strains of the disease and if successful could eventually be used worldwide.

He says several hundred babies will be involved in the trial.

"The children will start and enrol in the trial at 6 to 12 weeks of age, and we will immunise them at two months of age, four months of age, and six months," he said.

"We'll see the children again at 12 months and at that stage we'll be checking the memory of the immune response."

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.